| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | indisulam | CTRPv2 | pan-cancer | AAC | 0.0015 | 1 |
| mRNA | PI-103 | GDSC1000 | pan-cancer | AAC | 0.0013 | 1 |
| mRNA | MPS-1-IN-1 | GDSC1000 | pan-cancer | AAC | 0.0014 | 1 |
| mRNA | LE-135 | CTRPv2 | pan-cancer | AAC | -0.0015 | 1 |
| mRNA | GSK-1904529A | GDSC1000 | pan-cancer | AAC | -0.0013 | 1 |
| mRNA | A-443654 | GDSC1000 | pan-cancer | AAC | 0.0019 | 1 |
| mRNA | Bosutinib | GDSC1000 | pan-cancer | AAC | -0.0012 | 1 |
| mRNA | tamatinib | CTRPv2 | pan-cancer | AAC | -0.0013 | 1 |
| mRNA | decitabine:carboplatin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.001 | 1 |
| mRNA | cediranib | CTRPv2 | pan-cancer | AAC | 0.0017 | 1 |